- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07296744
Pivotale randomiserte studier av SUpira-systemet hos pasienter som gjennomgår høyrisiko perkutan koronarintervensjon (HRPCI) (SUPPORT II)
Pivotalt randomisert studie av SUpira-systemet hos pasienter som gjennomgår høyrisiko perkutan koronarintervensjon (HRPCI)
The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercially available Impella systems (comparator device).
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The Supira System is a minimally invasive percutaneous ventricular assist device (pVAD) that is intended to provide temporary hemodynamic support (≤ 4 hours) to patients undergoing HRPCI. The Supira Catheter is inserted percutaneously through the femoral artery, across the aortic valve, and into the left ventricle under fluoroscopic guidance, with the pump outlet remaining in the ascending aorta. The pump portion of the Catheter compresses during insertion in the Introducer Sheath and re-expands during use. It actively unloads the left ventricle by pumping blood from the ventricle into the ascending aorta and systemic circulation.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Supira Medical
- Telefonnummer: (669) 330-0883
- E-post: clinical@supiramedical.com
Studer Kontakt Backup
- Navn: Chris DeMorett
Studiesteder
-
-
California
-
Loma Linda, California, Forente stater, 92354
- Rekruttering
- Loma Linda University Medical Center
-
Hovedetterforsker:
- VInoy Prasad, M.D.
-
Ta kontakt med:
- Vinoy Prasad, M.D.
- Telefonnummer: 909-558-4200
- E-post: khefflin@llu.edu
-
Sacramento, California, Forente stater, 95817
- Rekruttering
- UC Davis
-
Ta kontakt med:
- Garrett Wong, M.D.
-
Hovedetterforsker:
- Garrett Wong, M.D.
-
Thousand Oaks, California, Forente stater, 91360
- Rekruttering
- Los Robles Regional Medical Center
-
Hovedetterforsker:
- Saibal Kar, M.D.
-
Ta kontakt med:
- Saibal Kar, M.D.
- Telefonnummer: 805-852-9100
- E-post: mane.arabyan@hcahealthcare.com
-
-
Florida
-
Miami, Florida, Forente stater, 33136
- Rekruttering
- University of Miami
-
Ta kontakt med:
- Barbara Lang
- Telefonnummer: 305-243-4950
- E-post: blang@med.miami.edu
-
Hovedetterforsker:
- Aditya Bharadwaj, M.D.
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30322
- Rekruttering
- Emory University Hospital
-
Hovedetterforsker:
- Bill Nicholson, M.D.
-
Ta kontakt med:
- Bill Nicholson, M.D.
- E-post: wei.xu@emory.edu
-
Atlanta, Georgia, Forente stater, 30309
- Rekruttering
- Piedmont Heart Institute
-
Ta kontakt med:
- David Kandzari, M.D.
-
Hovedetterforsker:
- David Kandzari, M.D.
-
Lawrenceville, Georgia, Forente stater, 30046
- Rekruttering
- Northside Hospital
-
Ta kontakt med:
- Troy Crain
- Telefonnummer: 678-312-3828
- E-post: Troy.Crain@northside.com
-
Hovedetterforsker:
- Michele Voeltz, M.D.
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Rekruttering
- Northwestern University
-
Ta kontakt med:
- Joaquim Barboza, M.D.
- Telefonnummer: 312-664-3278
- E-post: droshevs@nm.org
-
Hovedetterforsker:
- Joaquim Barboza, M.D.
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48236
- Rekruttering
- Henry Ford Health / St. John Hospital
-
Ta kontakt med:
- Amir Kaki, M.D.
-
Hovedetterforsker:
- Amir Kaki, M.D.
-
-
Minnesota
-
Saint Cloud, Minnesota, Forente stater, 56362
- Rekruttering
- CentraCare
-
Ta kontakt med:
- Stephen Kidd, M.D.
-
Hovedetterforsker:
- Stephen Kidd, M.D.
-
-
Missouri
-
St Louis, Missouri, Forente stater, 63110
- Rekruttering
- Washington University in St. Louis
-
Hovedetterforsker:
- John Lasala, M.D.
-
Ta kontakt med:
- John Lasala, M.D.
- Telefonnummer: 314-362-1291
- E-post: cjenifer@wustl.edu
-
-
New Jersey
-
Camden, New Jersey, Forente stater, 08103
- Rekruttering
- Virtua Health
-
Ta kontakt med:
- Kristin Wade
- Telefonnummer: 856-355-1225
- E-post: KMWADE@virtua.org
-
Hovedetterforsker:
- Kintur Sanghvi, M.D>
-
Paramus, New Jersey, Forente stater, 07652
- Rekruttering
- The Valley Hospital
-
Ta kontakt med:
- Kimberly Michel
- Telefonnummer: 201-447-8453
- E-post: KMICHEL@Valleyhealth.com
-
Hovedetterforsker:
- Raj Tayal, M.D.
-
-
New York
-
Buffalo, New York, Forente stater, 14203
- Rekruttering
- University of Buffalo (Buffalo General)
-
Hovedetterforsker:
- Vijay Iyer, M.D.
-
Ta kontakt med:
- Vijay Iyer, M.D.
- Telefonnummer: 716-710-8266
- E-post: ehejna@buffalo.edu
-
New York, New York, Forente stater, 10032
- Rekruttering
- Cuimc/Nyph
-
Ta kontakt med:
- Megha Prasad, M.D.
-
Hovedetterforsker:
- Megha Prasad, M.D.
-
Underetterforsker:
- Ajay Kirtane, M.D.
-
The Bronx, New York, Forente stater, 10467
- Rekruttering
- Montefiore Medical Center
-
Ta kontakt med:
- Andrea Mignatti, M.D.
-
Hovedetterforsker:
- Andrea Mignatti, M.D.
-
-
North Carolina
-
Asheville, North Carolina, Forente stater, 28803
- Rekruttering
- Mission Health
-
Ta kontakt med:
- Josie Routhier
- Telefonnummer: 828-274-6001
- E-post: Josephine.Routhier@HCAHealthcare.com
-
Hovedetterforsker:
- Michael Chenier, M.D.
-
-
Ohio
-
Columbus, Ohio, Forente stater, 43214
- Rekruttering
- OhioHealth
-
Hovedetterforsker:
- Arash Arshi, M.D.
-
Ta kontakt med:
- Arash Arshi, M.D.
- Telefonnummer: 614-262-6772
- E-post: joanna.flores-jones@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Forente stater, 74104
- Rekruttering
- Oklahoma Heart Hillcrest Medical
-
Hovedetterforsker:
- Kamran Muhammad, M.D.
-
Ta kontakt med:
- Kamran Muhammad, M.D.
-
-
Oregon
-
Portland, Oregon, Forente stater, 97239
- Rekruttering
- OHSU
-
Ta kontakt med:
- Firas Zahr, M.D.
- Telefonnummer: 503-494-1775
- E-post: sampsonna@ohsu.edu
-
Hovedetterforsker:
- Firas Zahr, M.D.
-
Portland, Oregon, Forente stater, 97225
- Rekruttering
- Providence
-
Ta kontakt med:
- Sheryl Ames
- Telefonnummer: 503-216-2099
- E-post: Sheryl.Ames@providence.org
-
Hovedetterforsker:
- Kathryn Dawson, M.D.
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Rekruttering
- University of Pennsylvania
-
Ta kontakt med:
- Joyce Wald, D.O.
- Telefonnummer: 215-615-4949
- E-post: alyson.brown@pennmedicine.upenn.edu
-
Hovedetterforsker:
- Joyce Wald, D.O.
-
Hovedetterforsker:
- Jay Giri, M.D.
-
York, Pennsylvania, Forente stater, 17403
- Rekruttering
- Wellspan York Hospital
-
Hovedetterforsker:
- Rhian Davies, D.O.
-
Ta kontakt med:
- Rhian Davies, D.O.
- Telefonnummer: 717-851-5153
- E-post: hmckinney@wellspan.org
-
-
South Carolina
-
Columbia, South Carolina, Forente stater, 29203
- Rekruttering
- Prisma Health
-
Hovedetterforsker:
- Vince Vismara, M.D.
-
Ta kontakt med:
- Vince Vismara, M.D.
- Telefonnummer: 803-434-3800
- E-post: Suzanne.Smith@PrismaHealth.org
-
-
Texas
-
Plano, Texas, Forente stater, 75093
- Rekruttering
- Baylor Scott & White The Heart Hospital
-
Hovedetterforsker:
- Karim Al-Azizi, M.D.
-
Ta kontakt med:
- Karim Al-Azizi, M.D.
- Telefonnummer: 469-800-6300
- E-post: Osniel.GonzalezRamos@BSWHealth.org
-
-
Utah
-
Murray, Utah, Forente stater, 84107
- Rekruttering
- Intermountain Health
-
Ta kontakt med:
- Savanna Chhak
- Telefonnummer: 801-507-4731
- E-post: Savanna.Chhak@imail.org
-
Hovedetterforsker:
- Mitul Patel, M.D.
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Hemodynamically stable and will undergo elective or urgent (not emergent) HRPCI, where hemodynamic support is deemed necessary, as determined by the institutional Heart Team
- Informed consent granted by the subject or legally authorized representative
Exclusion Criteria:
- Cardiogenic shock or acutely decompensated pre-existing chronic heart failure
- Stroke within 6 months of the index procedure, or any prior stroke with permanent neurologic deficit
- Left ventricular thrombus
- Aortic and iliofemoral anatomical conditions that preclude safe delivery and placement of the investigational device or the comparator device
- Ongoing renal replacement therapy with dialysis
- Presence of decompensated liver disease; severe liver dysfunction
- Infection of the proposed procedural access site or active infection
- Known hypersensitivity to intravenous contrast agents that cannot be adequately pre-medicated or known hypersensitivity to heparin, aspirin, adenosine diphosphate (ADP) receptor inhibitors, or nitinol
- Any condition, coagulopathy, planned procedure or contraindication that requires discontinuation of antiplatelet and/or anticoagulant therapy within 90 days of the index procedure
- Breastfeeding or pregnant or planning to become pregnant within 90 days of the HRPCI procedure
- Currently participating in active follow-up phase of another clinical study of an investigational drug or device or planning to enroll in such a study within 90 days of the HRPCI procedure
- Other medical, social, or psychological problems that, in the opinion of the Investigator, compromises the subject's ability to provide written informed consent and/or to comply with study procedures
- Considered to be part of a vulnerable population per the investigator's assessment
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Supira System
Subjects receiving the Supira System |
The Supira System is a temporary (≤ 4 hours) ventricular support device indicated for use during elective or urgent HRPCI performed in hemodynamically stable patients with severe coronary artery disease when a heart team has determined HRPCI is the appropriate therapeutic option. |
|
Aktiv komparator: Impella
Subjects receiving the Impella |
The current commercially available Impella CP with SmartAssist Catheter is indicated for providing temporary (≤ 6 hours) ventricular support during elective or urgent high risk percutaneous coronary i |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Composite Safety and Efficacy Outcomes
Tidsramme: 30 days
|
|
30 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Secondary Outcome Measures
Tidsramme: 30 and 90 days
|
Individual rates of the following outcomes:
|
30 and 90 days
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CP-10004
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .